|
| |
|
Sify.com » Topics » Indian drug companies
Indian drug companies News
Drug firms to gain from US patent expiries Lipitor-like exclusivity awaits Indian drug companies as 46 patents expire in 2012-15. On Tuesday, India’s leading drug maker Ranbaxy announced the launch of an authorised generic version of Pfizer drug Caduet in the United States. A week earlier, the same company had launched a low cost generic version of Pfizer’s biggest revenue earning drug, Lipitor, in the US market. The launch of these
Brand booster for pharma
Major Indian drug companies are creating their own identity abroad through direct selling.
Pharmaceutical companies reduce FCCB burden by 60%
Indian drug companies have reduced their cumulative foreign currency convertible bond (FCCB) burden by over 60 per cent. This has helped the companies improve their financial health and look for
'Made in India' dominates US AIDS scheme
Indian drug companies have cornered an overwhelming majority of drug approvals under the US President's Emergency Plan for AIDS Relief (Pepfar). Out of the 100 approvals by the US drug regulator Food |
|
|
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre. Site optimized for Internet Explorer 5.5 and above. See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise | |
